Inhibition of EZH2 or MALAT1 induces miR-29b expression, thereby downregulating major miR-29b pro-survival targets such as SP1, CDK6, and MCL-1 and reducing MM cell growth55. The gene discussed is EZH2; the disease is Miyoshi myopathy.